Exact Sciences
EXAS
EXAS was delisted on the 20th of March, 2026.
646 hedge funds and large institutions have $20.2B invested in Exact Sciences in 2021 Q1 according to their latest regulatory filings, with 99 funds opening new positions, 263 increasing their positions, 180 reducing their positions, and 68 closing their positions.
46% more repeat investments, than reductions
Existing positions increased: 263 | Existing positions reduced: 180
46% more first-time investments, than exits
New positions opened: 99 | Existing positions closed: 68
4% more funds holding
Funds holding: 622 → 646 (+24)
4% more capital invested
Capital invested by funds: $19.3B → $20.2B (+$815M)
0% more funds holding in top 10
Funds holding in top 10: 10 → 10 (0)
1.15% less ownership
Funds ownership: 91.7% → 90.55% (-1.1%)
30% less call options, than puts
Call options by funds: $204M | Put options by funds: $291M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
+$525M |
| 2 |
Baillie Gifford & Co
Edinburgh,
United Kingdom
|
+$438M |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$239M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$124M |
| 5 |
CC
Casdin Capital
New York
|
+$120M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$294M |
| 2 |
Capital World Investors
Los Angeles,
California
|
-$259M |
| 3 |
Wells Fargo
San Francisco,
California
|
-$228M |
| 4 |
JP Morgan Chase
New York
|
-$190M |
| 5 |
1832 Asset Management
Toronto,
Ontario, Canada
|
-$113M |
EXAS Hedge Fund Activity: Q1 2021 in Review
646 of the 5,696 institutional investors tracked by Wall St. Rank reported a position in Exact Sciences (EXAS) for Q1 2021, worth a combined $20.2B — up 4.2% from $19.3B a quarter earlier.
Buyers outnumbered sellers: 99 funds opened new EXAS positions and 68 closed out — a net gain of 31 holders — while 263 added to existing stakes and 180 trimmed.
The largest buyer was ARK Investment Management, adding an estimated $525M. The largest seller was Wellington Management Group, cutting an estimated $294M.
- 646 institutional investors held Exact Sciences (EXAS) as of Q1 2021, up from 622 in Q4 2020.
- Funds reported $20.2B of Exact Sciences stock for Q1 2021, up 4.2% quarter-over-quarter.
- 99 funds opened new Exact Sciences positions in Q1 2021 and 68 closed out, a net change of +31 holders.
- The largest Exact Sciences buyer in Q1 2021 was ARK Investment Management, an estimated $525M added.
- The largest Exact Sciences seller in Q1 2021 was Wellington Management Group, an estimated $294M sold.
Based on aggregated 13F filings for Q1 2021.